CSIMarket
 
Societal Cdmo Inc   (NASDAQ: SCTL)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 95
 Employees 300
 Revenues (TTM) (Millions $) 95
 Net Income (TTM) (Millions $) -13
 Cash Flow (TTM) (Millions $) -7
 Capital Exp. (TTM) (Millions $) 8

Business Description


Societal CDMO Inc is a bi-coastal contract development and manufacturing organization, providing end-to-end regulatory support, clinical and commercial manufacturing, packaging, and logistics services to the global pharmaceutical market. They specialize in small molecules, handling DEA-controlled substances, and developing and manufacturing modified-release dosage forms. They have three state-of-the-art facilities, totaling 145,000 square feet, in Gainesville, Georgia and San Diego, California. They have expertise in solving complex manufacturing problems and are a leading CDMO in the industry. They also manufacture key products, including Ritalin LA, Focalin XR, Verelan PM, Verelan SR, Verapamil PM, Verapamil SR, and Donnatal liquids and tablets. Societal CDMO's mission is to improve patient lives through client partnerships, and their vision is to be a premier, trusted CDMO by bringing tailored solutions to their clients while fostering engaging and rewarding careers for their people. Their strategy for growth includes executing segment-specific sales and marketing strategies, building stronger visibility and identity for the organization, enhancing both customerse and employeese experiences, and continuing to achieve growth and strengthen their financial position.


   Company Address: 1 E. Uwchlan Ave, Suite 112 Exton 19341 PA
   Company Phone Number: 534-8239   Stock Exchange / Ticker: NASDAQ SCTL


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CDMO        0.4% 
CORT   -1.98%    
CTLT        0.38% 
TMO   -1.35%    
• View Complete Report
   



Merger and Acquisition

CoreRx, Inc. Expands Footprint in CDMO Sector with Acquisition of Societal CDMO, Inc.

Published Mon, Apr 8 2024 8:06 PM UTC

CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.
Clearwater, Fla., April 08, 2024 - CoreRx, Inc. (CoreRx), a leading contract development and manufacturing organization (CDMO), has recently finalized its acquisition of Societal CDMO, Inc. (Societal CDMO) (Nasdaq: SCTL). This strategic move aims to strengthen CoreRx s capabilities in solving complex formulation a...

Merger and Acquisition

Groundbreaking Acquisition of Societal CDMO by CoreRx Inc. Set to Revolutionize the CDMO Industry

Published Wed, Feb 28 2024 9:29 PM UTC



In a recent press release, Societal CDMO Inc. announced its definitive agreement to be acquired by CoreRx, Inc., a leading pharmaceutical Contract Development and Manufacturing Organization (CDMO). The partnership aims to establish a highly comprehensive CDMO with unparalleled capabilities encompassing early-stage formulation development through to commercial manuf...

Contract

Powerhouse Partnership: Societal CDMO and Benuvia Uphold Drug Development in Psychedelic and Cannabinoid Markets

Published Thu, Feb 1 2024 12:01 PM UTC

Societal CDMO and Benuvia Sign Co-Marketing Agreement to Boost Drug Development Services in Thriving Psychedelic and Cannabinoid MarketsTwo prominent players in the contract development and manufacturing organization (CDMO) and active pharmaceutical ingredient (API) manufacturing services, Societal CDMO and Benuvia, have recently joined forces through a co-marketing agreemen...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.17
Working Capital Ratio 1.09
Leverage Ratio (MRQ) 1.53
Total Debt to Equity 0.63
Interest Coverage (TTM) 0.58
Debt Coverage (TTM) 0.15

Per Share Current
Earnings (TTM) -0.16 $
Revenues (TTM) 0.99 $
Cash Flow (TTM) -
Cash 0.09 $
Book Value 0.62 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 315,450
Net Income per Employee (TTM) -44,247
Receivable Turnover Ratio (TTM) 6.1
Inventory Turnover Ratio (TTM) 6.51
Asset Turnover Ratio (TTM) 0.64

Profitability Ratios Current
Gross Margin (MRQ) 27.77 %
Operating Margin (MRQ) 6.31 %
Net Margin (MRQ) -2.84 %
Net Cash Flow Margin (MRQ) -0.22 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.